Resource Logo
NLM AIDSLINE

Human immunodeficiency virus type 1 antigenemia in children.




 

J Pediatr. 1989 Jun;114(6):940-5. Unique Identifier : AIDSLINE

Human immunodeficiency virus type 1 (HIV-1) core antigen was assayed in the plasma of children at risk for infection with HIV to determine its usefulness in the diagnosis of infection and to correlate it with the clinical stage of disease. Antigen was detected in the plasma of all children less than 15 months of age with acquired immunodeficiency syndrome (AIDS). Two thirds of children with AIDS-related illnesses and half of children with asymptomatic infection had antigen. Although 53% of plasma specimens originating from HIV-infected children younger than 6 months of age contained antigen, only 25% of plasma specimens from children younger than 6 months who had no symptoms and none of the 10 specimens from HIV-infected newborn infants contained antigen. Half of the specimens containing core antigen also contained anticore antibody. Quantitative mean antigen levels were more likely to be elevated in children with AIDS (516 pg/ml) than in children with AIDS-related illnesses (295 pg/ml) or in those who had no symptoms (70 pg/ml). Antigen levels tended to increase over time in children with advancing clinical illness, but they tended to decrease over time after a diagnosis of AIDS was made. Antigen was detected in the plasma of 4 of 14 children without symptoms who subsequently reverted to an HIV seronegative state. We conclude that the detection of core antigen occurs with high frequency in children, even young infants, with symptomatic HIV infection. Plasma core antigen was less frequent in children without symptoms and was not detected in 10 infected children when they were tested at birth.

Acquired Immunodeficiency Syndrome/*DIAGNOSIS/IMMUNOLOGY AIDS-Related Complex/DIAGNOSIS/IMMUNOLOGY Comparative Study Enzyme-Linked Immunosorbent Assay Human HIV Antigens/*ANALYSIS HIV Seropositivity/IMMUNOLOGY HIV-1/*IMMUNOLOGY Infant Infant, Newborn Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. Viral Core Proteins/*IMMUNOLOGY JOURNAL ARTICLE



 




Information in this article was accurate in September 30, 1989. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.